Literature DB >> 29579336

Risk profile analysis and complications after surgery for autoimmune thyroid disease.

O Thomusch1, C Sekulla2, F Billmann3, G Seifert1, H Dralle2, K Lorenz2.   

Abstract

BACKGROUND: Surgical approaches to autoimmune thyroid disease are currently hampered by concerns over postoperative complications. Risk profiles and incidences of postoperative complications have not been investigated systematically, and studies with sufficient power to show valid data have not been performed.
METHODS: A prospective multicentre European study was conducted between July 2010 and December 2012. Questionnaires were used to collect data prospectively on patients who had surgery for autoimmune thyroid disease and the findings were compared with those of patients undergoing surgery for multinodular goitre. Logistic regression analysis was used to evaluate risk factors for thyroid surgery-specific complications, transient and permanent recurrent laryngeal nerve (RLN) palsy and hypoparathyroidism.
RESULTS: Data were available for 22 011 patients, of whom 18 955 were eligible for analysis (2488 who had surgery for autoimmune thyroid disease and 16 467 for multinodular goitre). Surgery for multinodular goitre and that for autoimmune thyroid disease did not differ significantly with regard to general complications. With regard to thyroid surgery-specific complications, the rate of temporary and permanent vocal cord palsy ranged from 2·7 to 6·7 per cent (P = 0·623) and from 0·0 to 1·4 per cent (P = 0·600) respectively, whereas the range for temporary and permanent hypoparathyroidism was 12·9 to 20·0 per cent (P < 0·001) and 0·0 to 7·0 per cent (P < 0·001) respectively. In logistic regression analysis of transient and permanent vocal cord palsy, autoimmune thyroid disease was not an independent risk factor. Autoimmune thyroid disease, extent of thyroid resection, number of identified parathyroid glands and no autotransplantation were identified as independent risk factors for both transient and permanent hypoparathyroidism.
CONCLUSION: Surgery for autoimmune thyroid disease is safe in comparison with surgery for multinodular goitre in terms of general complications and RLN palsy. To avoid the increased risk of postoperative hypoparathyroidism, special attention needs to be paid to the parathyroid glands.
© 2018 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29579336     DOI: 10.1002/bjs.10770

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  Accreditation of endocrine surgery units.

Authors:  Thomas J Musholt; Robert Bränström; Reto Martin Kaderli; Nuria Muñoz Pérez; Marco Raffaelli; Michael J Stechman
Journal:  Langenbecks Arch Surg       Date:  2019-09-07       Impact factor: 3.445

Review 2.  Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis-European Society of Endocrine Surgeons (ESES) positional statement.

Authors:  Kerstin Lorenz; Marco Raffaeli; Marcin Barczyński; Leyre Lorente-Poch; Joan Sancho
Journal:  Langenbecks Arch Surg       Date:  2020-06-10       Impact factor: 3.445

3.  The significance of Hashimoto's thyroiditis for postoperative complications of thyroid surgery: a systematic review and meta-analysis.

Authors:  X Gan; J Feng; X Deng; F Shen; J Lu; Q Liu; W Cai; Z Chen; M Guo; B Xu
Journal:  Ann R Coll Surg Engl       Date:  2021-03       Impact factor: 1.951

4.  Targeted use of intraoperative frozen-section analysis lowers the frequency of completion thyroidectomy.

Authors:  J I Staubitz; I Elmrich; P B Musholt; R J A Cámara; F Watzka; H Dralle; C Sekulla; K Lorenz; T J Musholt
Journal:  BJS Open       Date:  2021-03-05

5.  Short-Term Outcomes of Surgery for Graves' Disease in Germany.

Authors:  Elisabeth Maurer; Christian Vorländer; Andreas Zielke; Cornelia Dotzenrath; Moritz von Frankenberg; Hinrich Köhler; Kerstin Lorenz; Theresia Weber; Joachim Jähne; Antonia Hammer; Knut A Böttcher; Katharina Schwarz; Carsten Klinger; Heinz J Buhr; Detlef K Bartsch
Journal:  J Clin Med       Date:  2020-12-11       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.